Replies to post #15773 on Momenta Pharmaceuticals, Inc. (MNTA)

[biotech_researcher]

Well, this NVS selling of MNTA is going to take the wind out of the sails for awhile...

During the past three days (including today), NVS sold ~260K shares, reducing its MNTA holding from 4.71M shares to 4.45M shares.

[10nisman]

NVS established a 10b5-1 plan to sell its MNTA shares between 8/8/16 and 1/26/17:

https://www.sec.gov/Archives/edgar/data/1114448/000110465916138659/a16-16346_1sc13da.htm

During the past three days (including today), NVS sold ~260K shares, reducing its MNTA holding from 4.71M shares to 4.45M shares.

Any reason why NVS would prefer doing a 10b5-1 sale vs. a secondary offering? Not enough institutional demand for their shares?

10nis

[DewDiligence]

NVS’ 10b5-1 selling has (as of 8/26/16) reduced NVS’ holding in MNTA to 3.32M shares:

https://www.sec.gov/Archives/edgar/data/1114448/000110465916142120/a16-17495_1sc13da.htm

On 8/10/16 (the date of the previous 13D filing), NVS owned 4.45M shares.

p.s. Now that NVS’ equity stake in MNTA has fallen below 5%, no additional 13D filings are necessary, as far as I know.